Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxin Che

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|January 4, 2008
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase RhoDaotai Nie, Yande Guo, Dianer Yang, et al.
International Journal of Cancer|February 17, 2007
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer modelJulian J Raffoul, Sanjeev Banerjee, Mingxin Che, et al.
The American Journal of Surgical Pathology|May 18, 2005
A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinomaN Volkan Adsay, Olca Basturk, Michelle Bonnett, et al.
The American Journal of Pathology|January 27, 2004
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motilityDaotai Nie, Mingxin Che, Alex Zacharek, et al.
Human Gene Therapy|March 12, 2005
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii proteinYu Wang, Minzhen Xu, Mingxin Che, et al.
Molecular Cancer Therapeutics|October 16, 2004
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic modelGilda G Hillman, Yu Wang, Omer Kucuk, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapyGilda G Hillman, Richard L Maughan, David J Grignon, et al.
The American Journal of Pathology|March 29, 2005
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissueZhong Dong, R Daniel Bonfil, Sreenivasa Chinni, et al.
Cancer Research|January 21, 2006
Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancerYuxiang Zhang, Sanjeev Banerjee, Zhiwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Research|January 4, 2008
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase RhoDaotai Nie, Yande Guo, Dianer Yang, et al.
International Journal of Cancer|February 17, 2007
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer modelJulian J Raffoul, Sanjeev Banerjee, Mingxin Che, et al.
The American Journal of Surgical Pathology|May 18, 2005
A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinomaN Volkan Adsay, Olca Basturk, Michelle Bonnett, et al.
The American Journal of Pathology|January 27, 2004
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motilityDaotai Nie, Mingxin Che, Alex Zacharek, et al.
Human Gene Therapy|March 12, 2005
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii proteinYu Wang, Minzhen Xu, Mingxin Che, et al.
Molecular Cancer Therapeutics|October 16, 2004
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic modelGilda G Hillman, Yu Wang, Omer Kucuk, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapyGilda G Hillman, Richard L Maughan, David J Grignon, et al.
The American Journal of Pathology|March 29, 2005
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissueZhong Dong, R Daniel Bonfil, Sreenivasa Chinni, et al.
Cancer Research|January 21, 2006
Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancerYuxiang Zhang, Sanjeev Banerjee, Zhiwei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.
Pageof 3